{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T04:41:38Z","timestamp":1765082498578,"version":"3.46.0"},"reference-count":22,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,7,16]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Multimodal treatment prolongs the survival of patients with biliary tract cancer (BTC). However, the chemotherapy choices for this disease are few, and completing each chemotherapy session is important. Adjuvant chemotherapy has been attempted for BTC, but has only had a 75% completion rate. Body weight loss and cholangitis are reasons for the interruption of chemotherapy. Previous reports suggested that nutritional intervention with omega-3 fatty acids maintained body weight and improved the completion rate for chemotherapy. Moreover, omega-3 fatty acids have an anti-inflammatory effect. Therefore, we theorised that omega-3 fatty acids would improve the completion rate of adjuvant chemotherapy in patients with BTC. The aim of this study is thus to evaluate the effectiveness of omega-3 fatty acids for patients planning adjuvant chemotherapy for BTC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method and analysis<\/jats:title>\n                    <jats:p>This study is a single-centre, open-label, single-arm, historically controlled study with a planned enrolment of 55 participants. Protocol treatment consists of four courses of S-1 adjuvant chemotherapy and an oral omega-3 fatty acid pharmaceutic adjuvant (LOTRIGA 2\u2009g (Takeda Pharmaceutical Co.)), which includes 2\u2009g of omega-3 fatty acids from day 1 until day 168 of the treatment period. The primary endpoint is the completion rate of four total courses of S-1. Secondary endpoints are postoperative cholangitis, time to recurrence or distant metastasis, changes in nutritional index, changes in the lymphocyte blast transformation test induced by phytohaemagglutinin, and concanavalin A and diamine oxidase serum activity during adjuvant chemotherapy. All adverse events will be evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This protocol was approved by the Institutional Review Board of Kobe University Hospital. The findings from this study will be presented at national and international conferences and published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>UMIN000031247.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-029915","type":"journal-article","created":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T13:05:52Z","timestamp":1565442352000},"page":"e029915","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of omega-3 fatty acid administration on completion rate of adjuvant chemotherapy for biliary tract cancer: study protocol for a single-centre, open-label, single-arm, historically controlled study"],"prefix":"10.1136","volume":"9","author":[{"given":"Kimihiko","family":"Ueno","sequence":"first","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Ajiki","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tsugawa","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Akita","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Awazu","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Mukubo","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kuramitsu","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachio","family":"Terai","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motofumi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirichika","family":"Toyama","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kido","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,8,10]]},"reference":[{"key":"2025120619114881000_9.8.e029915.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-008-0015-0"},{"key":"2025120619114881000_9.8.e029915.2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5604\/16652681.1226927","article-title":"Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes","volume":"16","author":"Waseem","year":"2017","journal-title":"Ann Hepatol"},{"key":"2025120619114881000_9.8.e029915.3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10147-018-1283-6","article-title":"Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer","volume":"23","author":"Nakachi","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2025120619114881000_9.8.e029915.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072252"},{"key":"2025120619114881000_9.8.e029915.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30583-9"},{"key":"2025120619114881000_9.8.e029915.6","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1245\/s10434-012-2776-6","article-title":"Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer","volume":"20","author":"Aoyama","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2025120619114881000_9.8.e029915.7","first-page":"2289","article-title":"[Effect of enteral nutrition enriched with eicosapentaenoic acid on body weight loss and compliance with S-1 adjuvant chemotherapy after gastric cancer surgery]","volume":"40","author":"Aoyama","year":"2013","journal-title":"Gan To Kagaku Ryoho"},{"key":"2025120619114881000_9.8.e029915.8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25709"},{"key":"2025120619114881000_9.8.e029915.9","doi-asserted-by":"publisher","DOI":"10.1038\/nature13479"},{"key":"2025120619114881000_9.8.e029915.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052838","article-title":"N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth","volume":"7","author":"Cao","year":"2012","journal-title":"PLoS One"},{"key":"2025120619114881000_9.8.e029915.11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jhn.12471","article-title":"Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial","volume":"30","author":"Chagas","year":"2017","journal-title":"J Hum Nutr Diet"},{"key":"2025120619114881000_9.8.e029915.12","first-page":"7145","article-title":"Induction of apoptosis by eicosapentaenoic acid in esophageal squamous cell carcinoma","volume":"34","author":"Mizoguchi","year":"2014","journal-title":"Anticancer Res"},{"key":"2025120619114881000_9.8.e029915.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2004.12.013"},{"key":"2025120619114881000_9.8.e029915.14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jjco\/hyy004","article-title":"A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan clinical Oncology Group study (JCOG1202, Ascot)","volume":"48","author":"Nakachi","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"2025120619114881000_9.8.e029915.15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jhbp.314","article-title":"Biliary tract cancer registry in Japan from 2008 to 2013","volume":"23","author":"Ishihara","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2025120619114881000_9.8.e029915.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2934-5","article-title":"Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients","volume":"16","author":"Seo","year":"2016","journal-title":"BMC Cancer"},{"key":"2025120619114881000_9.8.e029915.17","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1245\/s10434-014-4280-7","article-title":"Postoperative serum albumin level is a marker of incomplete adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma","volume":"22","author":"Matsumoto","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2025120619114881000_9.8.e029915.18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3164\/jcbn.08-264","article-title":"Effects of caloric intake on intestinal mucosal morphology and immune cells in rats treated with 5-fluorouracil","volume":"45","author":"Murakami","year":"2009","journal-title":"J Clin Biochem Nutr"},{"key":"2025120619114881000_9.8.e029915.19","first-page":"318","article-title":"Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression","volume":"50","author":"Merluzzi","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"2025120619114881000_9.8.e029915.20","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11196"},{"key":"2025120619114881000_9.8.e029915.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04020.x"},{"key":"2025120619114881000_9.8.e029915.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0261-5614(02)00211-X"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-029915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:12:02Z","timestamp":1765077122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-029915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,10]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bmjopen-2019-029915"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-029915","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}